So sánh phương pháp
Xem các phương pháp đã chọn cạnh nhau; những hàng khác biệt được làm nổi bật.
| AGHDA: Đánh giá Thiếu hụt Hormone Tăng trưởng ở Người trưởng thành× | AddiQoL: Thang đo Chất lượng Cuộc sống trong Suy thượng thận× | |
|---|---|---|
| Lĩnh vực | Nội tiết học | Nội tiết học |
| Họ | Process / pipeline | Process / pipeline |
| Năm ra đời≠ | 2000 | 2012 |
| Người khởi xướng≠ | Anthony Hunt, Garry Werther, Peter Wrightson | Adriana Evers, Jeanieke Tiemensma |
| Loại | Patient self-report questionnaire | Patient self-report questionnaire |
| Công trình gốc≠ | Hunt, A. E., Werther, G. A., & Wrightson, P. (2000). The utility of AGHDA in identifying GH-deficient adults. Clin Endocrinol (Oxf), 52(3), 341-346. link ↗ | Evers, A. C., & Tiemensma, J. (2012). AddiQoL: A disease-specific quality of life scale for patients with primary adrenal insufficiency. J Clin Endocrinol Metab, 97(10), 3501-3508. link ↗ |
| Tên gọi khác≠ | AGHDA-25 | Addison Quality of Life, AI-QoL |
| Liên quan | 3 | 3 |
| Tóm tắt≠ | The AGHDA is a 25-item disease-specific quality of life questionnaire designed to assess the burden of adult growth hormone (GH) deficiency. Developed by Hunt, Werther, and colleagues in 2000, it evaluates symptoms and functional impairments directly related to GH deficiency, including fatigue, reduced muscle strength, weight gain, and psychological difficulties. The instrument is widely used in endocrinology practice and clinical trials to quantify the impact of GH replacement therapy. | AddiQoL is a disease-specific quality of life questionnaire developed to assess the burden of primary and secondary adrenal insufficiency, encompassing physical, emotional, and social domains relevant to patients on glucocorticoid and mineralocorticoid replacement therapy. Developed by Evers and Tiemensma in 2012, it is the first formally validated instrument specifically designed for adrenal insufficiency populations. |
| ScholarGateBộ dữ liệu ↗ |
|
|